StockSelector.com
  Research, Select, & Monitor Tuesday, September 22, 2020 10:51:19 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Sangamo Therapeutics, Inc.$10.22($.09)(.87%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Sangamo Therapeutics, Inc. has an overall rank of 1560 out of 7756 stocks based on 11 positive rankings and 6 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $21.00 for Sangamo Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Sangamo Therapeutics is ranked 99.
Highest Cash Growth
Sangamo Therapeutics rank is 153
PEGValue
Sangamo Therapeutics has a PEG Value of $42.52. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 312.41% in the next year. Among companies with a PEG Value above the current stock price, Sangamo Therapeutics is ranked 307.
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Sangamo Therapeutics is ranked 374.
Estimated Revenue Growth
Sangamo Therapeutics rank is 582
Low Put/Call
Sangamo Therapeutics has a low Put/Call ratio of 0.18 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Sangamo Therapeutics is ranked 628.
Historic Revenue Growth
Sangamo Therapeutics rank is 738
Debt-to-Equity
Sangamo Therapeutics rank is 980
Low vPut/Call
Sangamo Therapeutics has a low Put/Call ratio of 0.36 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Sangamo Therapeutics is ranked 986.
10 Day Gain
Sangamo Therapeutics rank is 1115
90 Day Gain
Sangamo Therapeutics rank is 3414
Negative Rankings
Price-to-Sales
Sangamo Therapeutics rank is 499
Negative Net Margin
Sangamo Therapeutics rank is 542
Down EPS Surprise
Sangamo Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROE
Sangamo Therapeutics rank is 1050
Negative ROA
Sangamo Therapeutics rank is 1113
Price-to-Book
Sangamo Therapeutics rank is 1723







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.